Literature DB >> 7388945

A secreted glycoprotein induced by estrogen in human breast cancer cell lines.

B Westley, H Rochefort.   

Abstract

Estrogen induces the synthesis of a glycoprotein of molecular weight 46,000 daltons in three estrogen receptor-positive breast cancer cell lines (MCF7, ZR75 and T47D), but not in an estrogen receptor-negative cell line (BT 20) or a nonmalignant cell line (HBL 100). The 46K protein, which accounts for 40% of 35S-methionine incorporation into secreted proteins, is only induced by steroids able to interact with the estrogen receptor. The anti-estrogens tamoxifen and hydroxytamoxifen, which by themselves were inactive, suppressed the induction of this protein by estradiol. In MCF7 cells, estradiol also induces three intracellular proteins which are resolved in two-dimensional electrophoresis. The induction of the 46K secreted protein(s) makes these cell lines excellent in vitro systems for studying the mechanism of estrogen and anti-estrogen action. This protein may also be a useful probe for studying the action of estrogen on breast cancer growth, and may be a useful marker for predicting the hormonal responsiveness of breast cancer in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7388945     DOI: 10.1016/0092-8674(80)90621-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  82 in total

1.  High expression of the trefoil protein TFF1 in interval breast cancers.

Authors:  M Crosier; D Scott; R G Wilson; C D Griffiths; F E May; B R Westley
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 2.  The application of 2D gel-based proteomics methods to the study of breast cancer.

Authors:  Robert C Stein; Marketa J Zvelebil
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

3.  Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells.

Authors:  L Klein-Hitpass; A C Cato; D Henderson; G U Ryffel
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

4.  Effect of histone H1 on estrogen receptor status of human breast cancer MCF 7 cells.

Authors:  G Vani; C S Shyamala Devi
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

5.  Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma.

Authors:  Xiao-Feng Huang; Chun-Mei Wang; Xiao-Wen Dai; Zhen- Jiang Li; Bo-Rong Pan; Li-Bin Yu; Bin Qian; Li Fang
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

6.  Different regions of the estrogen receptor are required for synergistic action with the glucocorticoid and progesterone receptors.

Authors:  A C Cato; H Ponta
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

7.  MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.

Authors:  D K Ways; C A Kukoly; J deVente; J L Hooker; W O Bryant; K J Posekany; D J Fletcher; P P Cook; P J Parker
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Effect of the anti-oestrogen tamoxifen on the development of renal cortical necrosis induced by oestrone + vasopressin administration in rats.

Authors:  J Kocsis; G Karácsony; S Karcsú; F A László
Journal:  Br J Exp Pathol       Date:  1988-04

9.  Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables.

Authors:  S Veneroni; M G Daidone; G Di Fronzo; V Cappelletti; D Amadori; A Riccobon; A Paradiso; M Correale; R Silvestrini
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.

Authors:  R Poulin; D Baker; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.